Tumanggong, Abdul Rahman .

HRN: 19-63-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2022
CEFUROXIME 750MG (VIAL)
08/05/2022
08/10/2022
IVT
250mg
Q8
Uti, Urti
Waiting Final Action 
08/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2022
08/13/2022
IV
100mg
Q8hrs
Amoebiasis
Waiting Final Action 
08/09/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/09/2022
08/13/2022
ORAL
4ml
Q8
Intestinal Amebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: